Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates For The Next Quarter

Related ABAX
Stocks Hitting 52-Week Highs
Cerus (CERS) in Focus: Stock Moves 5.9% Higher - Tale of the Tape
Related VIVO
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI
Meridian Bioscience Down to Strong Sell - Analyst Blog

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.

Abaxis (NASDAQ: ABAX) is estimated to post earnings of $0.24 per share in the June quarter. Abaxis' trailing-twelve-month revenue is $178.79 million.

Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.22 per share in the June quarter. Meridian Bioscience's trailing-twelve-month operating margin is 29.72%.

SurModics (NASDAQ: SRDX) is likely to earn $0.22 per share in the June quarter. SurModics had $30.96 million in total cash for the latest quarter.

Trinity Biotech plc (NASDAQ: TRIB) may earn $0.20 per share in the March quarter. Trinity Biotech's PEG ratio is 1.88.

Posted-In: Diagnostic Substances Industry Highest EPS Estimates small-cap stocksTrading Ideas

 

Related Articles (ABAX + SRDX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters